Hardy Diagnostics

Hardy Diagnostics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Hardy Diagnostics is a well-established, employee-owned provider of diagnostic and laboratory products, operating for over 40 years. The company has built a diversified portfolio across clinical diagnostics, pharmaceutical quality control, food safety, and cosmetics testing, supported by ten distribution centers. Its business model combines manufacturing, particularly of its proprietary HardyCHROM™ chromogenic media and sample collection systems, with distribution services, emphasizing regulatory support (e.g., 510(k), AOAC) and instrument servicing. Hardy Diagnostics positions itself as a reliable, service-oriented partner in the microbiology lab supply chain.

Diagnostics

Technology Platform

Proprietary chromogenic culture media (HardyCHROM™), rapid immunochromatographic and biochemical tests, environmental monitoring systems (TRIO series), and sample collection/transport systems.

Funding History

1
UndisclosedUndisclosed

Opportunities

Growth is driven by the persistent need for antimicrobial resistance (AMR) detection, expanding regulatory requirements in pharmaceutical and cannabis quality control, and the demand for customized lab solutions.
The company's service offerings, like regulatory support and instrument servicing, provide higher-margin revenue streams.

Risk Factors

Key risks include intense competition from large multinational corporations, potential technological disruption from molecular diagnostics, and the commoditization of basic lab supplies.
The company also faces regulatory compliance risks and supply chain vulnerabilities for raw materials.

Competitive Landscape

Hardy Diagnostics competes with global giants like BD, bioMérieux, Thermo Fisher, and Merck KGaA, as well as other specialty media manufacturers. It differentiates through its employee-owned service culture, US manufacturing, broad portfolio across multiple testing sectors, and strong regulatory support services.